ATS 2024 Final Program

Click on the session title to view the speakers

132

MONDAY • MAY 20

208 Clinical Immunological Characteristics of Anti-Interferon- g Autoantibodies Syndrome: A Prospective Cohort Study 209 Favorable Outcomes of Intermittent Biweekly Macrolide Plus Parenteral Agents in Mycobacterium Abscessus Subsp. Abscessus Pulmonary Disease 210 Bellevue Bronchiectasis Clinic: A Unique New York City Public Hospital Experience 211 The Role of Clofazimine as a First or Second Line Drug in Non-Tuberculous Mycobacteria Pulmonary Disease: Outcomes of Patients in an East London Cohort 212 CFTR Modulators Associated With Favorable Post-transplant Outcomes and Abrogate Macrophage Inflammatory Responses to Pseudomonas Aeruginosa 213 Morphological Quantitative Evaluation of the Airway Using Supine and Upright Computed Tomography in Patients With Non-cystic Fibrosis Bronchiectasis and Nontuberculous Mycobacterial Pulmonary Disease 214 The Risk of NTM Pulmonary Infection and Trace Metal Exposure in Municipal Drinking Water Systems Across the United States 215 Pulmonary Hygiene Use in People Living With M. Avium Complex Pulmonary Disease 216 Incidence and Prevalence of Non-cystic Fibrosis Bronchiectasis in Japan 217 A Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors 218 Mycobacterium Chelonae Outbreak Investigation Among Hospitalized Patients 219 Comparison of the Clinical Features of Bronchiectasis Patients With and Without a History of Tobacco Use - Data From the National Bronchiectasis and NTM Research Registry Consortium 220 Discrepancies in Species Identification and Antibiotic Susceptibility Testing Between Labs in Non-tuberculous Mycobacteria 221 Molds in the Airway Secretions in Patients With Primary Ciliary Dyskinesia: A 21-year Observational Study

222 Prescription Patterns of Inhaled Mucolytic Therapy and the Risk of Nontuberculous Mycobacterial Pulmonary Infections in Bronchiectasis Patients: A Retrospective Cohort Study 223 Genotype, Drug Susceptibility Profiles and Associated Clinical Features of Mycobacterium Abscessus (Mabs) Isolates in Patients With Mabs Pulmonary and Extrapulmonary Disease 224 Non-Tuberculous Mycobacterium (NTM): An 11-year Retrospective Review in Ayrshire and Arran: A Rural/Semi-urban Population on the West Coast of Scotland 225 Applying the BSI Tool to Bronchiectasis Patients With NTM Pulmonary Disease B27 PULMONARY REHABILITATION: ONLINE RESOURCES, COMPLEX PATIENTS AND PALLIATIVE CARE 9:15 a.m. - 11:15 a.m. San Diego Convention Center Room 28C-E (Upper Level) Viewing/Discussion 9:15-10:00 Abstract Summaries 10:00-11:15 301 Pulmonary Rehabilitation Utilization and Completion by Disease State in the US Population (2014-2019) 302 Assessment of Online Videos as a Source of Information and Instruction for Pulmonary Rehabilitation 303 Characterizing the Content, Quality, and Readability of Internet Resources on Exercise Training and Pulmonary Manifestations in Ehlers-danlos Syndromes (EDS) and Generalized Hypermobility Spectrum Disorder (G-HSD) 304 Reviewing Clinical Applications of Chatbots Powered by Large Language Models: Learning CPET 305 Barriers to Exercise Rehabilitation in Canadian Patients With Pulmonary Hypertension BEHAVIORAL • CLINICAL RAPID POSTER DISCUSSION SESSION

ATS 2024 Conference Program • San Diego, CA